Over the Counter

Chris Bell, JD, vice president of business operations at API Warehouse, discusses proactive approaches in preventing fraudulent threats and staying compliant with DSCSA.

While experts agree there is no one-size-fits-all approach, addressing medication nonadherence among patients presents opportunities for pharmacists to set themselves apart as medication counselors.

Calvin Hunsicker, founder & chief product officer at SureCost, discusses ongoing pharmacy procurement challenges in 2025 and how his company is helping businesses tackle common obstacles.

While the new guidelines are reserved for critical care pharmacists in the ICU, they can be applied to other practice areas, highlighting the crucial role pharmacists play in health care.

After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.

Addressing the impacts on patients and the overall pharmacy market, Joey Mattingly, PharmD, MBA, PhD, discusses trends in pharmacies opening and closing across the country.

As Walgreens senior director of immunizations, Samantha Picking, PharmD, delved into the evolution of pharmacies’ immunization services as well as their dedication to vaccine uptake.

With a myriad of non-traditional pharmacy roles on the rise, Ashley Kay Pendrick, PharmD, owner of Prosper Rx Consulting, provided insights into the opportunities at hand for US pharmacists.

As researchers continue to measure the impacts of the COVID-19 pandemic on public health, Hashim Zaibak, PharmD, discusses the evolution of community pharmacies in a postpandemic world.

With the company’s dedication to providing crucial data for pharmacy stakeholders, IQVIA’s Lead Research Director Michael Kleinrock discussed the current trends in patients’ medication use.

Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.

With federal reform continuing to stall, Drug Topics caught up with Iowa State Representative Brett Barker, PharmD, to discuss how his state is regulating pharmacy benefit managers.

Following his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter caught up with Drug Topics to discuss the pharmacists’ role in diabetes management.

As state-level PBM reform heats up amid dire situations for many retail pharmacies, Walgreens Chief Pharmacy Officer Rick Gates joins Drug Topics to discuss ongoing industry challenges.

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.

Amid the continuously evolving role of pharmacists in today’s health care landscape, independent owners like Amina Abubakar, PharmD, AAHIVP, are advancing the profession through innovation.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.

During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

John Riggi, national advisor for cybersecurity and risk at the American Hospital Association, discusses how pharmacists can assess their store’s vulnerability to cyberattacks.

President of 3 Axis Advisors and CEO of 46brooklyn Research joins Drug Topics to discuss nuances surrounding pharmacy benefit managers and the way they are perceived in the public eye.

Amid record levels of advertisements for lifestyle medications on social media, Luke Turnock, PhD, discusses the global impact these trends may have on patients.

Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.

LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.

Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.

Jeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.